Table II. —Distribution of studies by limitations of functioning of rehabilitation interest (LFRI), disease phase, and rehabilitation setting.
| Classification | Current update (N.=41) |
Total 3rd edition (N.=148) |
|||
|---|---|---|---|---|---|
| N. | % | Citation | N. | % | |
| LFRI | |||||
| Nervous system structures/functions | 7 | 17.1 | 2-8 | 20 | 13.5 |
| Respiratory structures/functions | 11 | 26.8 | 9-19 | 53 | 35.8 |
| Digestive functions | 0 | 0 | 1 | 0.7 | |
| Cardiovascular functions | 0 | 0 | 4 | 2.7 | |
| Any other body structure and function | 20 | 48.8 | 20-39 | 58 | 39.2 |
| Any activity limitation and participation restriction | 3 | 7.3 | 40-42 | 13 | 8.8 |
| Disease phase | |||||
| Acute covid-19 infection | 6 | 14.6 | 8, 11-13, 33, 35 | 13 | 8.8 |
| Ongoing symptomatic COVID-19 | 5 | 12.2 | 9, 10, 30, 31, 39 | 36 | 24.3 |
| Post COVID-19 condition | 29 | 70.7 | 2, 3, 5-7, 14-29, 32, 34, 36-38, 40-42 | 96 | 64.9 |
| Impact of COVID-19 (any phase) on people with disability | 1 | 2.4 | 4 | 3 | 2.0 |
| Rehabilitation setting | |||||
| Rehabilitation in acute care | 3 | 7.3 | 11, 12, 35 | 5 | 3.4 |
| Postacute specialized | 3 | 7.3 | 6, 17, 20 | 5 | 3.4 |
| Postacute general | 2 | 4.9 | 23, 26 | 8 | 5.4 |
| Specialized outpatient | 1 | 2.4 | 37 | 7 | 4.7 |
| General outpatient | 0 | 0 | 2 | 1.3 | |
| Home-care | 3 | 7.3 | 13, 32, 33 | 13 | 8.8 |
| Rehabilitation in social assistance | 0 | 0 | 1 | 0.7 | |
| NA * | 29 | 70.7 | 2-5, 7-10, 14-16, 18, 19, 21, 22, 24, 25, 27-31, 34, 36, 38-42 | 107 | 72.3 |
NA: not applicable. *A high proportion of studies reported LFRI in COVID-19 survivors, without focusing on a rehabilitation program.